UPDATE: BMO Capital Starts Vitae Pharmaceuticals (VTAE) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Wedbush Starts Vitae Pharmaceuticals (VTAE) at Outperform
October 20, 2014 8:01 AM EDTWedbush initiated coverage on Vitae Pharmaceuticals (NASDAQ: VTAE) with an Outperform rating and a price target of $21.00.
Analyst Liana Moussatos said, "Vitae is a clinical-stage emerging pharmaceutical company leveraging its proprietary Contour® structure-based drug design platform to discover and develop optimized orally-dosed small-molecule drug... More
JMP Securities Starts Vitae Pharmaceuticals (VTAE) at Market Outperform
October 20, 2014 7:56 AM EDTJMP Securities initiated coverage on Vitae Pharmaceuticals (NASDAQ: VTAE) with an Market Outperform rating and a price target of $15.00.
For an analyst ratings summary and ratings history on Vitae Pharmaceuticals click here. For more ratings news on Vitae Pharmaceuticals click here.
Shares of Vitae Pharmaceuticals closed at $6.30 yesterday.
... MoreStifel Starts Vitae Pharmaceuticals (VTAE) at Buy
October 20, 2014 7:55 AM EDTStifel initiated coverage on Vitae Pharmaceuticals (NASDAQ: VTAE) with a Buy rating and a price target of $14.00.
For an analyst ratings summary and ratings history on Vitae Pharmaceuticals click here. For more ratings news on Vitae Pharmaceuticals click here.
Shares of Vitae Pharmaceuticals closed at $6.30 yesterday.
... More